Overview

Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

A randomized, open-label, fed, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-385 in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical